Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

Stuart B. Gleichenhaus, senior managing director at FTI Consulting, who has also served as an interim CEO/CFO of five healthcare companies

Beyond Traditional Strategy Consulting Firms: Why MBA Students Should Consider Turnaround, Restructuring Consulting

ByMichael Wong

September 1st 2026

Costco could become a curator of Medicare coverage rather than simply another place where Medicare insurance is advertised. Credit: Stock.Adobe.com/jetcityimage.

The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma

ByThani Jambulingam, PhD

August 25th 2026

2026 Pharm Exec Top 50 Companies

ByMichael Christel

August 14th 2026

From Value Imperative to Operating Reality: Rethinking Trust in Pharma

ByMorten Nielsen,Saule Serikova,Susan M. Snyder

August 14th 2026

Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs

ByMichael Christel,Glenn Hunzinger

August 14th 2026

Our View on 2022: Pharm Exec’s Annual Industry Outlook

Articles in this issue

Related Content

Beyond Traditional Strategy Consulting Firms: Why MBA Students Should Consider Turnaround, Restructuring Consulting

The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma

2026 Pharm Exec Top 50 Companies

From Value Imperative to Operating Reality: Rethinking Trust in Pharma

Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs

Trending on PharmExec

Your Questions Answered: The Biggest Pharma and Biotech Stories This Week

Advancements in Oral Treatments for IBD

FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults

Pharmaceutical Executive Daily: FDA Approves Zanvastro

Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky